Evidence map›Paper›PMID 34860252›Full record

ArticleThe Journal of cell biology2022

pVHL-mediated SMAD3 degradation suppresses TGF-β signaling.

Jun Zhou, Yasamin Dabiri, Rodrigo A Gama-Brambila, Shahrouz Ghafoory, Mukaddes Altinbay, Arianeb Mehrabi, Mohammad Golriz, Biljana Blagojevic, Stefanie Reuter, Kang Han and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of cell biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Von Hippel-Lindau/Hypoxia Inducible Factor Axis in Glioblastoma.International journal of molecular sciences · 2025
    Review
  6. Article
  7. Ang-1 and VEGF: central regulators of angiogenesis.Molecular and cellular biochemistry · 2025
    Review
  8. Article
  9. Review
  10. Generation of nanoscopic membrane curvature for membrane trafficking.Nature reviews. Molecular cell biology · 2023
    Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Jun Zhou *School of Biomedical Sciences, Hunan University, Changsha, China.ORCID 0000-0002-2101-9304
Yasamin Dabiri *Institute of Pharmacy and Molecular Biotechnology, Heidelberg University, Heidelberg, Germany.
Rodrigo A Gama-BrambilaBuchmann Institute for Molecular Life Sciences, Pharmaceutical Chemistry, Goethe University Frankfurt am Main, Frankfurt am Main, Germany.
Shahrouz GhafooryInstitute of Pharmacy and Molecular Biotechnology, Heidelberg University, Heidelberg, Germany.
Mukaddes AltinbayBuchmann Institute for Molecular Life Sciences, Pharmaceutical Chemistry, Goethe University Frankfurt am Main, Frankfurt am Main, Germany.ORCID 0000-0001-8253-6711
Arianeb MehrabiDepartment of General, Visceral and Transplantation Surgery, Heidelberg University, Heidelberg, Germany.
Mohammad GolrizDepartment of General, Visceral and Transplantation Surgery, Heidelberg University, Heidelberg, Germany.
Biljana BlagojevicInstitute of Pharmacy and Molecular Biotechnology, Heidelberg University, Heidelberg, Germany.
Stefanie ReuterUniversitätsklinikum Jena, Klinik für Innere Medizin III, Jena, Germany.ORCID 0000-0002-3805-4632
Kang HanInstitute of Pharmacy and Molecular Biotechnology, Heidelberg University, Heidelberg, Germany.
Anna SeidelInstitute of Pharmacy and Molecular Biotechnology, Heidelberg University, Heidelberg, Germany.ORCID 0000-0001-5059-3092
Ivan ĐikićBuchmann Institute for Molecular Life Sciences, Pharmaceutical Chemistry, Goethe University Frankfurt am Main, Frankfurt am Main, Germany.ORCID 0000-0001-8156-9511
Stefan WölflInstitute of Pharmacy and Molecular Biotechnology, Heidelberg University, Heidelberg, Germany.
Xinlai ChengInstitute of Pharmacy and Molecular Biotechnology, Heidelberg University, Heidelberg, Germany.ORCID 0000-0001-6441-3742
Heidelberg University · DEGoethe University Frankfurt · DEHunan University · CNJena University Hospital · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transforming growth factor β (TGF-β) signaling plays a fundamental role in metazoan development and tissue homeostasis. However, the molecular mechanisms concerning the ubiquitin-related dynamic regulation of TGF-β signaling are not thoroughly understood. Using a combination of proteomics and an siRNA screen, we identify pVHL as an E3 ligase for SMAD3 ubiquitination. We show that pVHL directly interacts with conserved lysine and proline residues in the MH2 domain of SMAD3, triggering degradation. As a result, the level of pVHL expression negatively correlates with the expression and activity of SMAD3 in cells, Drosophila wing, and patient tissues. In Drosophila, loss of pVHL leads to the up-regulation of TGF-β targets visible in a downward wing blade phenotype, which is rescued by inhibition of SMAD activity. Drosophila pVHL expression exhibited ectopic veinlets and reduced wing growth in a similar manner as upon loss of TGF-β/SMAD signaling. Thus, our study demonstrates a conserved role of pVHL in the regulation of TGF-β/SMAD3 signaling in human cells and Drosophila wing development.

Indexed as

ProteolysisSignal TransductionAnimalsDrosophila melanogasterHCT116 CellsHeLa CellsHumansProtein BindingProtein DomainsSmad2 ProteinSmad3 ProteinTransforming Growth Factor betaUbiquitin-Protein LigasesVon Hippel-Lindau Tumor Suppressor ProteinSmad2 ProteinSmad3 ProteinTransforming Growth Factor betaUbiquitin-Protein LigasesVHL protein, humanVon Hippel-Lindau Tumor Suppressor Protein

Identifiers

PMID34860252
PMCPMC8650352
OpenAlexW3217081262

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.